A new ketamine-based antidepressant raises hope — and questions
The anesthetic drug’s long-term effects on people aren’t clear
FAST RELIEF A new drug based on the anesthetic ketamine relieves depression in hard-to-treat cases, but its long-term consequences are unknown.
Janssen Pharmaceuticals, Inc.
This article is only available to Science News subscribers.
Subscribers, enter your e-mail address to access our archives.
